HK1067057A1 - Angiotensin peptide-carrier conjugates and uses thereof - Google Patents

Angiotensin peptide-carrier conjugates and uses thereof

Info

Publication number: HK1067057A1
Authority: HK; Hong Kong
Prior art keywords: conjugates; angiotensin; carrier conjugates; angiotensin peptide; peptide
Prior art date: 2001-10-05

Application number

HK04110188.7A

Other languages

English (en)

Original Assignee

Cytos Biotechnology Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-05

Filing date

2004-12-23

Publication date

2005-04-01

2002-01-18 Priority claimed from US10/050,902 external-priority patent/US7264810B2/en

2002-10-07 Priority claimed from PCT/EP2002/011219 external-priority patent/WO2003031466A2/en

2004-12-23 Application filed by Cytos Biotechnology Ag filed Critical Cytos Biotechnology Ag

2005-04-01 Publication of HK1067057A1 publication Critical patent/HK1067057A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0013—Therapeutic immunisation against small organic molecules, e.g. cocaine, nicotine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Biochemistry (AREA)
Mycology (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

HK04110188.7A 2001-10-05 2004-12-23 Angiotensin peptide-carrier conjugates and uses thereof HK1067057A1 (en)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US32699801P	2001-10-05	2001-10-05
US33104501P	2001-11-07	2001-11-07
US10/050,902 US7264810B2 (en)	2001-01-19	2002-01-18	Molecular antigen array
PCT/IB2002/000166 WO2002056905A2 (en)	2001-01-19	2002-01-21	Molecular antigen array
US39663702P	2002-07-19	2002-07-19
PCT/EP2002/011219 WO2003031466A2 (en)	2001-10-05	2002-10-07	Angiotensin peptide-carrier conjugates and uses thereof

Publications (1)

Publication Number	Publication Date
HK1067057A1 true HK1067057A1 (en)	2005-04-01

Family

ID=32996249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK04110188.7A HK1067057A1 (en)	2001-10-05	2004-12-23	Angiotensin peptide-carrier conjugates and uses thereof

Country Status (11)

Country	Link
EP (1)	EP2090319A3 (de)
JP (1)	JP2010189406A (de)
KR (1)	KR101015508B1 (de)
AT (1)	ATE421334T1 (de)
BR (1)	BR0213117A (de)
DE (1)	DE60230992D1 (de)
DK (1)	DK1432443T3 (de)
HK (1)	HK1067057A1 (de)
IL (1)	IL160286A0 (de)
MX (1)	MXPA04002644A (de)
PL (1)	PL369796A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20140048119A (ko) *	2011-04-15	2014-04-23	고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸	Ｄｎａ 백신
EP3244915A1 (de)	2015-01-15	2017-11-22	University of Copenhagen	Virusähnliche partikel mit effizienter epitopanzeige
ES2854726T3 (es)	2015-10-30	2021-09-22	The Univ Of Copenhagen	Partícula similar a virus con presentación eficiente de epítopos
US12194157B2 (en)	2020-04-09	2025-01-14	Finncure Oy	Carrier for targeted delivery to a host
AU2021252164A1 (en)	2020-04-09	2022-12-15	Finncure Oy	Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4722840A (en)	1984-09-12	1988-02-02	Chiron Corporation	Hybrid particle immunogens
US4918166A (en)	1987-04-10	1990-04-17	Oxford Gene Systems Limited	Particulate hybrid HIV antigens
NZ235315A (en)	1989-09-19	1991-09-25	Wellcome Found	Chimaeric hepadnavirus core antigen proteins and their construction
EP0463151B1 (de)	1990-01-12	1996-06-12	Cell Genesys, Inc.	Erzeugung xenogener antikörper
US5334394A (en)	1990-06-22	1994-08-02	The Regents Of The University Of California	Human immunodeficiency virus decoy
SE9003978D0 (sv)	1990-12-13	1990-12-13	Henrik Garoff	Dna expressionssystem baserade paa ett virus replikon
GB9101550D0 (en)	1991-01-24	1991-03-06	Mastico Robert A	Antigen-presenting chimaeric protein
GB9114003D0 (en)	1991-06-28	1991-08-14	Mastico Robert A	Chimaeric protein
GB9227068D0 (en)	1992-12-29	1993-02-24	British Bio Technology	Novel proteinaceous particles
WO1994017813A1 (en)	1993-02-08	1994-08-18	Paravax, Inc.	Defective sindbis virus vectors that express toxoplasma gondii p30 antigens
US6015686A (en)	1993-09-15	2000-01-18	Chiron Viagene, Inc.	Eukaryotic layered vector initiation systems
CN1185811A (zh)	1995-03-31	1998-06-24	H·沃尔夫	依赖于逆转录病毒样颗粒的抗原呈递系统
US5876727A (en)	1995-03-31	1999-03-02	Immulogic Pharmaceutical Corporation	Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
US5792462A (en)	1995-05-23	1998-08-11	University Of North Carolina At Chapel Hill	Alphavirus RNA replicon systems
ID18046A (id)	1996-08-20	1998-02-19	Takeda Chemical Industries Ltd	Senyawa siklik campuran, pembuatan dan penngunaannya.
US5770380A (en)	1996-09-13	1998-06-23	University Of Pittsburgh	Synthetic antibody mimics--multiple peptide loops attached to a molecular scaffold
ATE292143T1 (de) *	1997-06-24	2005-04-15	Proteus Molecular Design	Angiotensinderivate
CN100387622C (zh)	1998-02-12	2008-05-14	免疫合成物公司	策略性修饰的乙肝核心蛋白及其衍生物
SE9801923D0 (sv)	1998-05-29	1998-05-29	Independent Pharmaceutical Ab	Nicotine vaccine
AU770802B2 (en) *	1998-10-21	2004-03-04	Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The	Virus-like particles for the induction of autoantibodies
PL192016B1 (pl) *	1998-11-30	2006-08-31	Cytos Biotechnology Ag	Kompozycja, sposób wytwarzania sztucznego, uporządkowanego i powtarzalnego układu antygenu, zastosowanie kompozycji oraz kompozycja szczepionki
AP1836A (en)	2000-04-07	2008-03-14	Univ Of Leeds Innovations Limited	Hepatitis b core antigen fusion proteins.
AU2001252458A1 (en) *	2000-05-05	2001-11-20	Martin Bachmann	Molecular antigen arrays and vaccines
CA2413546C (en)	2000-06-22	2011-06-14	Celltech Pharmaceuticals Limited	Modification of hepatitis b core antigen
US20030138769A1 (en)	2000-08-16	2003-07-24	Birkett Ashley J.	Immunogenic HBc chimer particles having enhanced stability
US7264810B2 (en)	2001-01-19	2007-09-04	Cytos Biotechnology Ag	Molecular antigen array

2002
- 2002-01-21 BR BR0213117-0A patent/BR0213117A/pt not_active IP Right Cessation
- 2002-01-21 MX MXPA04002644A patent/MXPA04002644A/es active IP Right Grant
- 2002-10-07 DK DK02800605T patent/DK1432443T3/da active
- 2002-10-07 EP EP09150826A patent/EP2090319A3/de not_active Withdrawn
- 2002-10-07 KR KR1020047002222A patent/KR101015508B1/ko not_active Expired - Fee Related
- 2002-10-07 PL PL02369796A patent/PL369796A1/xx not_active Application Discontinuation
- 2002-10-07 DE DE60230992T patent/DE60230992D1/de not_active Expired - Lifetime
- 2002-10-07 IL IL16028602A patent/IL160286A0/xx not_active IP Right Cessation
- 2002-10-07 AT AT02800605T patent/ATE421334T1/de not_active IP Right Cessation
2004
- 2004-12-23 HK HK04110188.7A patent/HK1067057A1/xx not_active IP Right Cessation
2010
- 2010-04-01 JP JP2010085112A patent/JP2010189406A/ja active Pending

Also Published As

Publication number	Publication date
EP2090319A3 (de)	2009-10-28
DK1432443T3 (da)	2009-05-04
BR0213117A (pt)	2004-09-21
EP2090319A2 (de)	2009-08-19
MXPA04002644A (es)	2004-07-08
ATE421334T1 (de)	2009-02-15
KR20050034573A (ko)	2005-04-14
IL160286A0 (en)	2004-07-25
DE60230992D1 (de)	2009-03-12
KR101015508B1 (ko)	2011-02-16
JP2010189406A (ja)	2010-09-02
PL369796A1 (en)	2005-05-02

Publication	Publication Date	Title
WO2003031466A3 (en)	2003-10-23	Angiotensin peptide-carrier conjugates and uses thereof
MXPA03008715A (es)	2003-12-11	Reduccion de la inmunogenicidad de proteinas de fusion.
MXPA04006059A (es)	2004-09-27	Preparacion liofilizada que contiene anticuerpos contra el receptor del factor de crecimiento epidermico.
MY162525A (en)	2017-06-15	Process for concentration of antibodies and therapeutic products thereof
EP1553975B8 (de)	2023-04-12	Optimierte fc-varianten und herstellungsverfahren dafür
AU4673099A (en)	2000-09-14	Use of bioadhesives and adjuvants for the mucosal delivery of antigens
MXPA03006093A (es)	2005-02-14	Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
ATE252814T1 (de)	2003-11-15	Leuchstoff für lichtquellen und zugehörige lichtquelle
AP2003002752A0 (en)	2003-06-30	Immunogenic HBc Chimer particles having enhanced stability.
HK1046004A1 (en)	2002-12-20	Recombinant gelatins
AP2003002751A0 (en)	2003-06-30	Malaria immunogen and vaccine
AU2003296151A1 (en)	2004-07-22	Process for producing dipeptide
MXPA04004814A (es)	2004-08-11	Metodos para descubrir ligandos.
DE50005586D1 (de)	2004-04-15	Leuchtstoff für Lichtquellen und zugehörige Lichtquelle
MY127575A (en)	2006-12-29	Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
HK1067057A1 (en)	2005-04-01	Angiotensin peptide-carrier conjugates and uses thereof
MXPA03004986A (es)	2004-10-15	Proceso para preparar polimeros de emulsion con alta pureza.
ATE262600T1 (de)	2004-04-15	Herstellung von aluminium-silizium-legierungen
HK1063057A1 (en)	2004-12-10	Pharmaceutical composition of f(ab) 2 fragments of antibodies and method for the preparation thereof
AU2003267551A1 (en)	2004-03-11	Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
MXPA04004937A (es)	2004-08-11	Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
SG185137A1 (en)	2012-11-29	Biologically active peptides
DE59610629D1 (de)	2003-09-04	Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine
WO2003015813A3 (en)	2004-06-17	Anti-tumor vaccines
IL146257A0 (en)	2002-07-25	Method of producing methoxyimido acetic amide

Legal Events

Date	Code	Title	Description
2015-04-30	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20141007